CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 26 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $31,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,166,154 | $1,733,000 | 1.01% |
| CVI Holdings, LLC | 730,320 | $584,000 | 0.97% |
| SV Health Investors, LLC | 2,857,667 | $2,286,000 | 0.67% |
| Clarus Ventures, LLC | 2,008,192 | $1,606,000 | 0.38% |
| FEDERATED HERMES, INC. | 10,434,000 | $8,347,000 | 0.02% |
| OPPENHEIMER & CO INC | 508,415 | $407,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,000,000 | $800,000 | 0.01% |
| BOSTON FAMILY OFFICE LLC | 24,467 | $20,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,780 | $18,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 90,300 | $72,000 | 0.00% |